News
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...
Another preventive measure is monoclonal antibodies — artificially created proteins that can be given to infants to assist ...
The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...
An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...
The "magic rods" are surgically implanted and can be slowly lengthened with internal and external magnets. It is a less invasive treatment than traditional methods involving body casts and surgeries.
The CDC's Advisory Committee on Immunization Practices (ACIP) has issued new vaccine recommendations affecting RSV and flu ...
The FDA has given the green light to expand the use of Moderna's vaccine for the treatment of RSV, the virus that causes ...
A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...
This month’s cover story, entitled “Dubious Treatments, ‘Snake Oil Salesmen’ Grab Attention in Rheumatology,” features a stellar lineup of discussants, including Adam Brown, MD; Allan ...
Targeting the capsid protein of the hepatitis B virus (HBV) has emerged as a promising strategy for developing new antiviral therapies. In this study, we report the discovery of a novel series of ...
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59 The extension of the shot’s approval is a welcome win for company after recent setbacks Bill Sikes/AP By Helen Branswell June ...
News GlobeNewswire BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results